Steve N. Slilaty
Chief Executive Officer at Sunshine Biopharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Sunshine Biopharma Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Sunshine Biopharma Inc. December 11, 2025100.0%
-
Sunshine Biopharma Inc. December 10, 2024100.0%
-
Sunshine Biopharma Inc. December 7, 202390.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2024 | Sunshine Biopharma Inc. | Open-market purchase | +100,000 | $0.10 | $10,000 |
| Feb 8, 2024 | Sunshine Biopharma Inc. | Open-market purchase | +20,000 | $0.10 | $2,000 |
Questions about Steve N. Slilaty
What boards is Steve N. Slilaty on?
Steve N. Slilaty sits on the board of Sunshine Biopharma Inc.
What company is Steve N. Slilaty the CEO of?
Steve N. Slilaty is Chief Executive Officer of Sunshine Biopharma Inc.
How long has Steve N. Slilaty served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.